Type your tag names separated by a space and hit enter

Israel's COVID-19 endgame.
Science. 2021 05 14; 372(6543):663.Sci

Authors+Show Affiliations

Ran D. Balicer is founding director at the Clalit Research Institute and Chief Innovation Officer, Clalit Health Services, Tel Aviv, Israel; a professor at the School of Public Health, Ben Gurion University of the Negev, Be'er Sheva, Israel; and the chairman of Israel's COVID-19 National Expert Advisory Panel. rbalicer@clalit.org.il.Reut Ohana is deputy director at the Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel. reut.ohana@clalit.org.il.

Pub Type(s)




PubMed ID



Balicer, Ran D., and Reut Ohana. "Israel's COVID-19 Endgame." Science (New York, N.Y.), vol. 372, no. 6543, 2021, p. 663.
Balicer RD, Ohana R. Israel's COVID-19 endgame. Science. 2021;372(6543):663.
Balicer, R. D., & Ohana, R. (2021). Israel's COVID-19 endgame. Science (New York, N.Y.), 372(6543), 663. https://doi.org/10.1126/science.abj3858
Balicer RD, Ohana R. Israel's COVID-19 Endgame. Science. 2021 05 14;372(6543):663. PubMed PMID: 33986155.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Israel's COVID-19 endgame. AU - Balicer,Ran D, AU - Ohana,Reut, PY - 2021/5/14/entrez PY - 2021/5/15/pubmed PY - 2021/5/22/medline SP - 663 EP - 663 JF - Science (New York, N.Y.) JO - Science VL - 372 IS - 6543 SN - 1095-9203 UR - https://www.unboundmedicine.com/medline/citation/33986155/Israel's_COVID-19_endgame. L2 - https://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=33986155 DB - PRIME DP - Unbound Medicine ER -